Synapse - Mark Kris

Results (870)

Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors

Journal Article

Balak, M. N.; Gong, Y.; Riely, G. J.; Somwar, R.; Li, A. R.; Zakowski, M. F.; Chiang, A.; Yang, G.; Ouerfelli, O.; Kris, M. G.; more...
Clinical Cancer Research (2006)

Fulltext@MSK | Save

GM2, fucosyl GM1, globo H and polysialic acid are suitable targets for a tetravalent vaccine against SCLC

Meeting Abstract

Livingston, P.; Hood, C.; Krug, L. M.; Warren, N.; Kris, M. G.; Brezicka, T.; Ragupathi, G.
Cancer Research (2005)

Fulltext@MSK | Save

Pilot study of GD2 synthase transcript levels in small cell lung cancer (SCLC)

Meeting Abstract

Chen, L. C.; Cheung, I. Y.; Jones, J.; Kris, M. G.; Cheung, N. K. V.; Krug, L. M.
Cancer Research (2005)

Fulltext@MSK | Save

Morphologic features of lung adenocarcinomas in relation to responsiveness to epidermal growth factor receptor (EGFR) inhibitors and EGFR mutational status

Meeting Abstract

Zakowski, M. F.; Hussain, S.; Pao, W.; Miller, V. A.; Kris, M. G.
Modern Pathology (2005)

Fulltext@MSK | Save

Morphologic features of lung adenocarcinomas in relation to responsiveness to epidermal growth factor receptor (EGFR) inhibitors and EGFR mutational status

Meeting Abstract

Zakowski, M. F.; Hussain, S.; Pao, W.; Miller, V. A.; Kris, M. G.
Laboratory Investigation (2005)

Fulltext@MSK | Save

EGFR and KRAS mutational analysis of mucinous pneumonic bronchiololavelolar carcinomas

Meeting Abstract

Zakowski, M.; Ladanyi, M.; Kris, M.; Rusch, V.; Pao, W.
Lung Cancer (2005)

Fulltext@MSK | Save

Phase II trial of erlotinib in patients with bronchioloalveolar carcinoma

Meeting Abstract

Sandler, A.; Kris, M.; Miller, V.; Carbone, D.; Pao, W.; Billheimer, D.; Tsao, A.; Patel, J.; Johnson, B.; Johnson, D.
Lung Cancer (2005)

Fulltext@MSK | Save

A prospective study to correlate EGFR mutations with gefitinib response in early stage NSCLC

Meeting Abstract

Rizvi, N.; Pao, W.; Miller, V.; Rusch, V.; Heelan, R.; Ladanyi, M.; Ginex, P.; Tyson, L.; Zakowski, M.; Kris, M.
Lung Cancer (2005)

Fulltext@MSK | Save

Clinical characteristics and natural history of patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations treated with erlotinib or gefitinib

Meeting Abstract

Riely, G. J.; Miller, V. A.; Pao, W.; Zakowski, M.; Ladanyi, M.; Heelan, R. T.; Kris, M. G.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Lung adenocarcinomas with mutations in EGFR and KRAS have distinct gene expression profiles

Meeting Abstract

Pham, D.; Sarkaria, I.; Socci, N.; Pao, W.; Zakowski, M.; Miller, V.; Kris, M.; Rusch, V.; Singh, B.
Lung Cancer (2005)

Fulltext@MSK | Save